瘤血管神经信号:在癌症中提供新的准机会
Victor Oginga Oria1, Janine Terra Erler1
1Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, DK-2200 Copenhagen, Denmark.
Cells
|October 27, 2023
概括
内皮细胞通过分泌血管分泌因子,积极塑造瘤,影响癌症的进展,转移和对治疗的抗性. 了解这种信号是开发新的癌症治疗方法的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
背景情况:
- 血管内皮提供氧气和营养,并通过血管生成支持癌症的进展.
- 对抗血管生成疗法的耐药性在癌症治疗中构成了重大挑战.
- 内皮细胞越来越多地被认为是瘤微环境中的积极参与者,不仅仅是血管生成.
研究的目的:
- 审查血管神经信号在癌症中的多方面的作用.
- 要突出内皮细胞如何影响瘤进展,转移和治疗阻力.
- 强调了解内皮细胞信号对于新治疗策略的重要性.
主要方法:
- 关于内皮细胞和癌症的最新研究的文献综述.
- 对由内皮细胞分泌的血管质因子进行分析.
- 对瘤发生过程中内皮衍生信号的当前知识的综合.
主要成果:
- 内皮细胞分泌血管新生因子 (细胞因子,生长因子,化学因子),指导瘤微环境.
- 血管神经信号与远程转移,瘤休眠和转移前位形成有关.
- 内皮细胞信号传递有助于免疫逃避和抵抗癌症疗法.
结论:
- 血管神经信号在癌症进展的多个方面发挥着关键和复杂的作用.
- 向来自内皮细胞的信号为克服治疗耐药性和改善癌症治疗结果提供了潜力.
- 对内皮细胞信号的进一步研究对于推进瘤疗法至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


